Transforming growth factor-alpha (TGF-alpha), one of the ligands for the epidermal growth factor (EGF) receptor, is expressed in the pituitary gland as well as numerous other tissues. It has been postulated to play a role in the development of pituitary adenomas and cancers in tissues such as breast. TGF-alpha is normally expressed in lactotrophs and this expression is upregulated by estrogen prior to the development of lactotroph hyperplasia. In a transgenic mouse model in which we directed overexpression of TGF alpha to the lactotrophs, lactotroph hyperplasia and adenomata develop. To determine if EGF receptor signaling is required for the pituitary response to pregnancy and estrogen stimulation, we developed a transgenic mouse that expresses a dominant negative EGF receptor in the lactotrophs. The specificity of the growth stimulation to the lactotrophs by the TGF alpha targeted to these cells will be another focus of our investigations. TGF alpha is a general growth factor and the EGF receptor is widely dispersed in the pituitary in cells other than lactotrophs. We therefore propose to investigate how the action of TGF alpha is spatially confined within the pituitary. This question has important implication in development where general growth factor mediate growth responses in specific cell lineages. We propose experiments to test the role of the TGF alpha membrane anchor in the spatial limitation of TGF alpha activity in the pituitary by introducing mutations in the growth factor that either remove the anchor or prevent proteolytic processing. Transgenic mouse models will be created using these mutant TGF alpha precursors. We will also continue our studies of the TGF alpha promoter. We have defined several elements in the TGF alpha promoter which control transcription of this gene in cell cultures. We will extend these studies in transgenic animals to determine the segments of an elements within the TGF alpha promoter that direct expression of the gene to specific tissues such as pituitary, kidney, breast, brain and skin. We will also continue to study the role of p53 in TGF alpha gene expression. We have found that the TGF alpha promoter contains p53 binding sites that confer transcriptional activation upon the TGF alpha gene in response to p53. While a major function of p53 is in tumor suppression, this aspect of p53 function has the paradoxic role of allowing p53 to stimulate cell proliferation in response to DNA damage, thus providing a signal for epithelial repair. We propose to study whether the TGF alpha promoter can be activated by DNA damage in transgenic animals with an intact or knocked-out p53 gene. Together, these studies will test the function of the TGF alpha promoter in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043652-08
Application #
2770392
Study Section
Reproductive Endocrinology Study Section (REN)
Program Officer
Sato, Sheryl M
Project Start
1991-06-01
Project End
2000-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
8
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Wu, Jing; Bowe, Damon B; Sadlonova, Andrea et al. (2014) O-GlcNAc transferase is critical for transducin-like enhancer of split (TLE)-mediated repression of canonical Wnt signaling. J Biol Chem 289:12168-76
Huang, Ping; Ho, Shiuh-Rong; Wang, Kai et al. (2011) Muscle-specific overexpression of NCOATGK, splice variant of O-GlcNAcase, induces skeletal muscle atrophy. Am J Physiol Cell Physiol 300:C456-65
Ho, Shiuh-Rong; Wang, Kai; Whisenhunt, Thomas R et al. (2010) O-GlcNAcylation enhances FOXO4 transcriptional regulation in response to stress. FEBS Lett 584:49-54
Wang, Kai; Ho, Shiuh-Rong; Mao, Weiming et al. (2009) Increased O-GlcNAc causes disrupted lens fiber cell differentiation and cataracts. Biochem Biophys Res Commun 387:70-6
Bowe, Damon B; Sadlonova, Andrea; Toleman, Clifford A et al. (2006) O-GlcNAc integrates the proteasome and transcriptome to regulate nuclear hormone receptors. Mol Cell Biol 26:8539-50
Whisenhunt, Thomas R; Yang, Xiaoyong; Bowe, Damon B et al. (2006) Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. Glycobiology 16:551-63
Roh, Meejeon; Paterson, Andrew J; Liu, Kan et al. (2005) Proteolytic processing of TGFalpha redirects its mitogenic activity: the membrane-anchored form is autocrine, the secreted form is paracrine. Biochim Biophys Acta 1743:231-42
Roh, M; Paterson, A J; Asa, S L et al. (2001) Stage-sensitive blockade of pituitary somatomammotrope development by targeted expression of a dominant negative epidermal growth factor receptor in transgenic mice. Mol Endocrinol 15:600-13
Xie, W; Chow, L T; Paterson, A J et al. (1999) Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFalpha expression in transgenic mice. Oncogene 18:3593-607
Xie, W; Wu, X; Chow, L T et al. (1998) Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles. Cell Growth Differ 9:313-25

Showing the most recent 10 out of 29 publications